News from NYU Langone Health
People Magazine
Supermodel Anok Yai recently revealed she underwent robotic lung surgery for a congenital defect that was damaging her lungs. In a social media post, Yai shared photos from her recovery at NYU Langone Health and expressed gratitude for her treatment. She specifically thanked her surgeon, Robert J. Cerfolio, MD, MBA, chief, Division of Thoracic Surgery, director, Thoracic Surgery, NYU Langone Health, his team, and the nursing staff. Yai, who was recently named Model of the Year, is now healing from the procedure.
Also reporting was: Enstarz
12/21/2025
Beware this common disease that attacks from the inside — and the bad habit that worsens it
New York Post
In an article, Yamen Homsi, MD, section chief of the Department of Rheumatology at NYU Langone Hospital—Brooklyn, discusses rheumatoid arthritis (RA), an autoimmune disease causing painful swelling and stiffness. He explains that poor oral hygiene can exacerbate symptoms by increasing systemic inflammation. Dr. Homsi notes that while RA commonly starts in the hands and feet, there are effective treatments available, including three classes of disease-modifying antirheumatic drugs (DMARDs). He adds that the prognosis for RA has improved, allowing patients to live long, active lives. At NYU Langone Health, rheumatologists are available to help patients.
12/22/2025
A Patient’s Guide to End-Stage Renal Failure
U.S. News and World Report
End-stage renal failure (ESRF) is the final phase of chronic kidney disease, affecting over 815,000 people in the U.S. Diabetes and high blood pressure are the most common causes, accounting for three-quarters of all cases. According to David M Charytan, MD, director, Division of Nephrology, Department of Medicine at NYU Langone Health, diabetes is responsible for 40% to 50% of ESRF cases. Treatment options for the incurable condition include dialysis or a kidney transplant. The article notes that while a deceased donor kidney has a five-year waiting list, a living donor can expedite the process.
12/19/2025
100 great hospitals in America | 2025
Becker's Hospital Review
Becker's has named NYU Langone Health to its 'Great hospitals in America' list for 2025, highlighting its national leadership in quality, safety, and innovation. The profile notes NYU Langone's top Vizient rankings for 11 consecutive years, a 5-star CMS quality rating, and Magnet recognition across all its hospitals. The system is also recognized for its U.S. News & World Report rankings in 13 specialties. Recent breakthroughs mentioned include the nation’s first fully robotic lung transplant and a successful gene-edited pig kidney xenotransplant sustained for over four months. The system contributed $2.7 billion in community benefit in fiscal year 2023.
12/19/2025
NYU Langone’s annual toy drive brightens holidays for Sunset Park children
Brooklyn Paper
NYU Langone held its annual toy drive on 16 December at the NYU Langone Sunset Park Family Health Center Pediatrics Clinic to provide gifts for local children. The initiative is part of a broader effort to distribute over 5,400 educational gifts across its family health centers and hospital campuses in Brooklyn and Long Island. Isaac Dapkins, MD, chief medical officer for Family Health Centers at NYU Langone, stated the event provides holiday cheer and support for the community. Larry McReynolds, executive director for Family Health Centers at NYU Langone, added that the event reinforces the organization's commitment to community health.
12/19/2025
Gynecologists Say These Are the Best Vitamins for Vaginal Health
Prevention
An article on vaginal health highlights the impact of diet, recommending foods rich in probiotics, polyphenols, fiber, and vitamins D and E to support a healthy microbiome. Experts also advise against excessive sugar, high-glycemic foods, and saturated fats, which can disrupt bacterial balance. Meleen Chuang, MD, chief of obstetrics and gynecology at NYU Langone Hospital—Brooklyn, explains that a healthy diet helps good bacteria proliferate, likening the vaginal flora to a battle between good and evil bacteria.
12/19/2025
Remission From Prediabetes Halves CV Risk: Registry Data
TCTMD
A global registry meta-analysis found that achieving remission from prediabetes can substantially lower the risk of cardiovascular death or heart failure hospitalization decades later. The study, published in the Lancet Diabetes & Endocrinology, combined data from two long-term prevention programs. Commenting on the findings, Jonathan D. Newman, MD, MPH, assistant professor in the Department of Medicine at NYU Langone Health, clinical research director, Center for the Prevention of Cardiovascular Disease, called prediabetes a 'focused opportunity for prevention.' He noted the data is important for showing that early intervention can prevent long-term problems and highlighted a 'real legacy effect' when a patient is moved off the prediabetes track.
12/19/2025
Are The Holidays Giving You Headaches? NYU Neurologist Discusses Preventive Measures!
LongIsland.com
According to experts at NYU Langone Health, holiday-related headaches and migraines can be prevented. They advise planning in advance to reduce stress, not skipping meals, and avoiding trigger foods like processed meats and red wine. It is also recommended to limit exposure to strong scents, drink alcohol in moderation, and prioritize personal downtime. Maintaining regular sleep and eating schedules is crucial. For persistent issues, a neurologist can discuss new treatment options like CGRP-targeting medications.
12/22/2025
What’s Going Around | Common mistakes made by grandparents
DC News Now
Perri Klass, MD, professor in the Department of Pediatrics at NYU Grossman School of Medicine, discussed common mistakes grandparents make, referencing a column she wrote. She explained that tension over parenting decisions is common due to generational differences and changing times. Klass advised that while it is a dynamic and complicated process, families should give each other grace and work as a team. She also encouraged grandparents to trust their adult children, whom they raised to make good decisions, as they navigate parenthood in a different environment.
12/19/2025
Modifiable risk factors for Alzheimer's disease
Citrus County Chronicle
An article outlines several modifiable risk factors for Alzheimer's disease, a common form of dementia. According to NYU Langone Health, high blood pressure is a significant risk factor as it can damage small blood vessels in the brain, leading to reduced blood flow and inflammation. Other controllable factors discussed include type 2 diabetes, smoking, serious head trauma, and alcohol consumption. The global number of people with dementia is expected to rise from 55 million in 2020 to 139 million by 2050.
12/20/2025
Top Infectious Disease News Stories Week of December 13 - December 19
Contagion Live
A weekly infectious disease news roundup profiles NYU Langone Health’s Division of Pediatric Infectious Diseases in the Department of Pediatrics. Faculty and fellows provide clinical care to children with infectious diseases at Hassenfeld Children’s Hospital at NYU Langone, Fink Children’s Ambulatory Care Center, NYU Langone Orthopedic Hospital, and NYC Health + Hospitals/Bellevue. The division also provides fellowship training and education through its accredited program and medical student electives, offering trainees opportunities to learn about a wide range of infectious diseases and immunodeficiencies.
12/20/2025
The Aesthetic Edge: December 2025
Dermatology Times
A roundup of new aesthetic products highlights several innovations. Doris J. Day, MD, clinical associate professor in NYU Langone's Ronald O. Perelman Department of Dermatology, commented on the Stellar M22 with XPL Technology, an FDA-cleared device for treating over 30 skin indications. She noted the device's precision and versatility help patients achieve natural-looking results with minimal downtime. The article also discusses other products, including a serum for post-treatment skin, a prescription-strength formula for beard growth, stem cell-based hair care, and a peel serum with Micro-Spicule technology.
12/19/2025
He made beer that’s also a vaccine. Now controversy is brewing
Science News
A National Cancer Institute virologist has developed a potential polyomavirus vaccine delivered in home-brewed beer, sparking scientific and ethical controversy after self-experimenting. The unconventional approach has drawn criticism from experts concerned about sidestepping rigorous testing and fueling anti-vaccine sentiment. Among the critics is Art Caplan, PhD, the Drs. William F. and Virginia Connolly Mitty Professor of Bioethics in the Department of Population Health at NYU Grossman School of Medicine, who argued that this is a poor time to roll out a do-it-yourself vaccine, citing potential backlash and public distrust.
12/19/2025
DR MARC SIEGEL: Tell me your miracles and I will tell you the ones I am praying for
Fox News
In an opinion piece, Marc Siegel, MD, professor of medicine and medical director of Doctor Radio at NYU Langone Medical Center, discusses his new book, 'The Miracles Among Us.' He explores the concept of miracles in various forms, from divine intervention to advanced medical care. Dr. Siegel shares anecdotes from readers and reflects on recent tragedies, including a shooting at Brown University, emphasizing the role of prayer, faith, and medical science in healing and recovery. He also notes the successful initial medical response for the shooting victims at Rhode Island Hospital.
Also reporting was: KPC Media Group
12/20/2025
Diabetes Breakthrough: New Drug Shows Promise
Archyworldys
Researchers at NYU Langone Health have developed a new drug, RAGE406R, that shows promise in treating diabetes complications. Unlike current medications that manage blood sugar, this drug targets the underlying cellular inflammation that causes organ damage. The compound works by inhibiting the interaction between RAGE and DIAPH1 proteins, a key pathway in the inflammatory process. In studies on mice, RAGE406R significantly reduced inflammation and accelerated wound healing, a major issue for people with diabetes. The research, published in Cell Chemical Biology, is now moving towards human clinical trials to assess its safety and efficacy.
12/21/2025
The wellness wild west is back on its bullshit with unapproved weight loss drugs
The Verge
An article examines the trend of unapproved weight loss drugs, such as retatrutide, being sold through gray-market websites and promoted by social media influencers. The drug, dubbed 'GLP-3,' is still in clinical trials and not FDA-approved. Michael A. Weintraub, MD, clinical assistant professor in the Department of Medicine at NYU Langone Health, explains that the drug is not fully studied and its potential side effects are unknown. He warns that any website advertising or selling retatrutide cannot be trustworthy, highlighting the risks of using medications from compounding pharmacies without medical supervision.
12/19/2025
